Back to search

Article

NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2

2022-04-05

Abstract excerpt

<h4>Background: </h4> To investigate the role of NRF2 signaling in conferring superior prognosis in patients with HPV positive (HPV +ve ) head & neck squamous cell carcinomas (HNSCC) compared to HPV negative (HPV -ve ) HNSCC and develop molecular markers for selection of HPV +ve HNSCC patients for treatment de-escalation trials. <h4>Methods: </h4>: We compared NRF2 activity ( NRF2 , KEAP1 , and NRF2-transcriptiona...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ce761b4-5c1f-517e-99ba-51557ce8eb1b
DOI
10.21203/rs.3.rs-1504099/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2DOI 10.21203/rs.3.rs-1504099/v1
Select a neighboring publication to make it the new centre.